Building Upon 25 Years of Molecular Expertise
With a legacy spanning 25 years, Carolina Molecular Inc builds upon the pedigree of Gentris, Cancer Genetics, and Flagship Biosciences to deliver cutting-edge molecular testing services. We partner with CROs/CDMOs, CGT innovators, technology providers, and research institutions to extend the breadth and depth of their offerings, enabling breakthroughs in clinical diagnostics, discovery research, and product development.
Our Comprehensive Molecular Testing Solutions
Carolina Molecular leverages over two decades of molecular expertise to empower partners with advanced testing services across three strategic areas:
Clinical Testing
CAP/CLIA Certified
- Hematological NGS Panels
- Solid Tumor NGS Panel
- qPCR (PGx, Toxicity, Oncology, Infectious Disease)
- Sanger Sequencing
- nCounter Expression Profiling
NGS Foundry
High-throughput Sequencing
- Whole Genome Sequencing
- Whole Exome Sequencing
- Single Cell Analysis
- GeoMx Spatial Analysis
- Bioinformatic (BFx) Analysis
- RNA Sequencing
Quality Control
Identification and Characterization
- Product Identification
- Cell line characterization
- Molecular safety testing
- Environmental monitoring
Explore Our Applications Across the Research Pipeline
Clinical Trials & Molecular Diagnostics
Biomarker Discovery & Identification
Infectious Disease
Oncology & Immunology
Cell & Gene Therapy
Advanced Molecular Analysis Capabilities
Sample Extraction & Library Prep
- Blood
- Tissue
- FFPE
- Cells
- Biobanking and sample storage
Expression Profiling
- GeoMx Spatial
- Single-cell RNAseq
- RNAseq
- nCounter
Genomic Analysis
- Germline Sequencing
- Microbiome
- Epigenetics
- Minimal Residual Disease (MRD)
Why Partner with Carolina Molecular?
Trustworthy Clinical Expertise
- CAP/CLIA certified since 2010
- Over 50 validated molecular assays
- Supporting more than 200 clients
Hassle-Free Production Sequencing
- Transparent pricing and scheduling
- Rapid quote turnaround
- Direct communication with scientific team
- Primary analytics included
- operated under established QMS
State-of-the-Art Technology
- Illumina NovaSeqX Plus for high-throughput applications
- NextSeq and MiSeq platforms for targeted applications
- Advanced qPCR and Sanger sequencing capabilities
Comprehensive Analytics
- Primary, secondary, and tertiary analysis available
- Integrating NGS with other spatial data
- Specialized services tailored for clinical trials, discovery, and characterization projects
Ready to Enhance Your Capabilities?
Contact us today to discuss how Carolina Molecular can amplify your molecular testing capabilities and streamline your clinical, translational, and research projects.